Keywords: fda, backs, avapro, use, diabetic, renal, disease

FDA backs Avapro use in diabetic renal disease.

Article | 21 January 2002

Print This

The US Food and Drug Administration is in favor of the approval ofSanofi-Synthelabo/Bristol-Myers Squibb's Avapro (irbesartan) as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in